Tricida, Inc. (Nasdaq: TCDA) today announced that it will Report results from its blinded, 40-week extension
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
Tricida to Report Long-Term Clinical Trial Results for TRC101 in CKD Patients with Metabolic Acidosis and Host Conference Call and Webcast on Thursday, March 28, 2019
Tags:
report
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
